Dr. Vaishnav is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-7911
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2015 - 2018- Johns Hopkins UniversityResidency, Internal Medicine, 2013 - 2016
Saint Louis University School of MedicineClass of 2013
Certifications & Licensure
MD State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- A Study of AT-02 in Subjects With Systemic Amyloidosis. Start of enrollment: 2023 Sep 21
Roles: Contact
- Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis Start of enrollment: 2022 Sep 01
Roles: Contact
Publications & Presentations
PubMed
- 144 citationsEndomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac AmyloidosisVirginia S. Hahn, Lisa R. Yanek, Joban Vaishnav, Wendy Ying, Dhananjay Vaidya
JACC. Heart Failure. 2020-09-01 - 106 citationsMyocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.Virginia S. Hahn, Hildur Knutsdottir, Xin Luo, Kenneth Bedi, Kenneth B. Margulies
Circulation. 2021-01-12 - 64 citationsAngiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist ...Brian A. Houston, Andrea L.C. Schneider, Joban Vaishnav, David M. Cromwell, P. Elliott Miller
The Journal of Heart and Lung Transplantation. 2017-04-01
Journal Articles
- Clinical Research Randomized Evaluation of Heart Failure with Preserved Ejection Fraction Patients with Acute Heart Failure and Dopamine: The ROPA-DOP TrialJoban Vaishnav, David A Kass, Kavita Sharma, Nishant Shah, Allison Tsao, John Miller, Richa Gupta, David R Thiemann, Rohan Kalathiya, Steven P Schulman, Stuart D Russe..., ScienceDirect
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
